Clinical Trial Update: An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

This clinical trial update notes that the Phase 3 extension study of TS-152 in rheumatoid arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TS-152

Snippet

Sponsor: Taisho Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED